Healthcare · Pharmaceutical expenditure
In 2026, South Africa's pharmaceutical expenditure reached 1.25 % GDP of GDP, ranking 88th out of 197 countries. A large portion of this spending goes toward antiretroviral drugs and TB medications, reflecting the country's heavy disease burden. Domestic generic production is expanding, particularly in Gauteng and KwaZulu-Natal, but reliance on imports from India and China remains significant. Private pharmacies thrive in urban areas, while public hospitals often experience supply shortages.
Data for 2026 · unit: % GDP
Position
#88 / 197
South Africa world ranking
Country position on the scale from last to first place for this indicator.
ZA
#88
#197#1
Trend
Change over time
Change in indicator over the available period.
0.80
1990
1.00
2000
1.20
2010
1.20
2020
1.25
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where South Africa stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in South Africa — how much?
Based on 2026 data — 1.25 % GDP. This is rank #88 out of 197 countries.
What is South Africa's rank by Pharmaceutical expenditure?
South Africa ranks #88 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in South Africa?
Over the available period the indicator changed from 0.80 to 1.25 % GDP.